49 results on '"Jungner, Ingmar"'
Search Results
2. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
3. Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
4. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
5. Iron metabolism and risk of cancer in the Swedish AMORIS study
6. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
7. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
8. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
9. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study
10. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients
11. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis
12. Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
13. Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
14. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
15. Additional file 1: of Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
16. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy
17. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
18. Additional file 1: of Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
19. Additional file 1: of Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
20. Additional file 2: of Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
21. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
22. Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
23. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
24. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
25. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
26. Gunnar Jungner and the Principles and Practice of Screening for Disease
27. Serum inflammatory markers and colorectal cancer risk and survival
28. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
29. Cohort Profile: The AMORIS cohort
30. Additional file 1: of Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
31. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients : a competing risk analysis
32. Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
33. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
34. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
35. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
36. Serum lactate dehydrogenase and survival following cancer diagnosis
37. Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort
38. Serum Glucose and Lipids in Relation to Gastrointestinal Cancer Risk
39. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
40. Serum Calcium and Risk of Gastrointestinal Cancer
41. Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
42. Serum Glucose and Fructosamine in Relation to Risk of Cancer
43. Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study
44. Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
45. Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study
46. Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials
47. O-0019SERUM CALCIUM AND RISK OF GASTROINTESTINAL CANCER.
48. [Apolipoproteins are better risk markers than conventional lipids].
49. [Apolipoproteins are new and better risk indicators of myocardial infarction].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.